UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma

Oncogene, 2009-07, Vol.28 (27), p.2513-2523

2009

Volltextzugriff (PDF)

VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo

Oncogene, 2009-04, Vol.28 (14), p.1694-1705

2009

Volltextzugriff (PDF)

Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns

Genes & cancer, 2010-02, Vol.1 (2), p.152-163

2010

Volltextzugriff (PDF)

Integrative radiomics expression predicts molecular subtypes of primary clear cell renal cell carcinoma

Clinical radiology, 2018-09, Vol.73 (9), p.782-791

2018

Volltextzugriff (PDF)

Restoration of X-ray Resistance and V(D)J Recombination in Mutant Cells by Ku cDNA

Science (American Association for the Advancement of Science), 1994-10, Vol.266 (5183), p.288-291

1994

Volltextzugriff (PDF)

Involvement of the Ku Autoantigen in the Cellular Response to DNA Double-Strand Breaks

Proceedings of the National Academy of Sciences - PNAS, 1994-08, Vol.91 (16), p.7623-7627

1994

Volltextzugriff (PDF)

A DNA end-binding factor involved in double-strand break repair and V(D)J recombination

Molecular and Cellular Biology, 1994-07, Vol.14 (7), p.4741-4748

1994

Volltextzugriff (PDF)

Ku86 defines the genetic defect and restores X-ray resistance and V(D)J recombination to complementation group 5 hamster cell mutants

Molecular and Cellular Biology, 1996-04, Vol.16 (4), p.1519-1526

1996

Volltextzugriff (PDF)

Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma

Oncogenesis (New York, NY), 2017-01, Vol.6 (1), p.e287-e287

2017

Volltextzugriff (PDF)

Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth

Cancer cell, 2003, Vol.3 (1), p.75-88

2003

Volltextzugriff (PDF)

VHL: oxygen sensing and vasculogenesis

Journal of thrombosis and haemostasis, 2005-12, Vol.3 (12), p.2627-2632

2005

Volltextzugriff (PDF)

DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage

Cancer research (Chicago, Ill.), 1997, Vol.57 (1), p.68-74

1997

Volltextzugriff (PDF)

SETD2 Haploinsufficiency for Microtubule Methylation Is an Early Driver of Genomic Instability in Renal Cell Carcinoma

Cancer research (Chicago, Ill.), 2018-06, Vol.78 (12), p.3135-3146

2018

Volltextzugriff (PDF)

Pleiotropic Effects of the Trichloroethylene-Associated P81S VHL Mutation on Metabolism, Apoptosis, and ATM-Mediated DNA Damage Response

JNCI : Journal of the National Cancer Institute, 2013-09, Vol.105 (18), p.1355-1364

2013

Volltextzugriff (PDF)

Abstract 4495: DNA demethylation promotes ERV expression and activation of immune signaling in renal cell cancer cells

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4495-4495

2020

Volltextzugriff (PDF)

HIF Transcription Factor Expression and Induction of Hypoxic Response Genes in a Retroperitoneal Angiosarcoma

Anticancer research, 2004-01, Vol.24 (1), p.167-169

2004

Volltextzugriff (PDF)

Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2018-06, Vol.36 (16), p.1588-1593

2018

Volltextzugriff (PDF)

Failure of Hairpin-Ended and Nicked DNA To Activate DNA-Dependent Protein Kinase: Implications for V(D)J Recombination

Molecular and Cellular Biology, 1998-11, Vol.18 (11), p.6853-6858

1998

Volltextzugriff (PDF)

Renal cell carcinoma

Current opinion in oncology, 2005-05, Vol.17 (3), p.261-267

2005

Volltextzugriff (PDF)

In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations

Cancer research (Chicago, Ill.), 2004-12, Vol.64 (23), p.8595-8603

2004

Volltextzugriff (PDF)

A phase II trial of lapatinib in hormone refractory prostate cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.16037-16037

2008

Volltextzugriff (PDF)

Phase II trial of sorafenib plus interferon-alpha 2b (IFN-α2b) as first- or second-line therapy in patients (pts) with metastatic renal cell cancer (RCC)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.4538-4538

2006

Volltextzugriff (PDF)

Models of Von Hippel-Lindau tumor suppressor disease specific activity

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9553-9553

2004

Volltextzugriff (PDF)

Models of Von Hippel-Lindau tumor suppressor disease specific activity

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9553-9553

2004

Volltextzugriff (PDF)

Yersinia pseudotuberculosis bacteremia and splenic abscess in a patient with non-insulin-dependent diabetes mellitus

The Western journal of medicine, 1999-02, Vol.170 (2), p.110

1999

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Englisch
(119)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma

VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo

Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns

Integrative radiomics expression predicts molecular subtypes of primary clear cell renal cell carcinoma

Restoration of X-ray Resistance and V(D)J Recombination in Mutant Cells by Ku cDNA

Involvement of the Ku Autoantigen in the Cellular Response to DNA Double-Strand Breaks

A DNA end-binding factor involved in double-strand break repair and V(D)J recombination

Ku86 defines the genetic defect and restores X-ray resistance and V(D)J recombination to complementation group 5 hamster cell mutants

Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma

Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth

VHL: oxygen sensing and vasculogenesis

DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage

SETD2 Haploinsufficiency for Microtubule Methylation Is an Early Driver of Genomic Instability in Renal Cell Carcinoma

Pleiotropic Effects of the Trichloroethylene-Associated P81S VHL Mutation on Metabolism, Apoptosis, and ATM-Mediated DNA Damage Response

Abstract 4495: DNA demethylation promotes ERV expression and activation of immune signaling in renal cell cancer cells

HIF Transcription Factor Expression and Induction of Hypoxic Response Genes in a Retroperitoneal Angiosarcoma

Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma

Failure of Hairpin-Ended and Nicked DNA To Activate DNA-Dependent Protein Kinase: Implications for V(D)J Recombination

Renal cell carcinoma

In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations

A phase II trial of lapatinib in hormone refractory prostate cancer

Phase II trial of sorafenib plus interferon-alpha 2b (IFN-α2b) as first- or second-line therapy in patients (pts) with metastatic renal cell cancer (RCC)

Models of Von Hippel-Lindau tumor suppressor disease specific activity

Models of Von Hippel-Lindau tumor suppressor disease specific activity

Yersinia pseudotuberculosis bacteremia and splenic abscess in a patient with non-insulin-dependent diabetes mellitus

Suchergebnisse filtern